Bausch Health Cos Market Cap 2006-2019 | BHC
Bausch Health Cos market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Bausch Health Cos market cap as of January 21, 2020 is $10.48B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $10.478B | $8.380B |
| Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allergan (AGN) | Ireland | $63.220B | 11.52 |
| Mylan (MYL) | United States | $11.174B | 5.01 |
| Teva Pharmaceutical Industries (TEVA) | Israel | $10.943B | 4.45 |
| Dr Reddy's Laboratories (RDY) | India | $7.056B | 18.51 |
| ASPEN PHARMACR (APNHY) | South Africa | $3.747B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.295B | 12.53 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.938B | 48.76 |
| Homology Medicines (FIXX) | United States | $0.726B | 0.00 |
| Mallinckrodt Public (MNK) | United Kingdom | $0.508B | 0.69 |
| Voyager Therapeutics (VYGR) | United States | $0.496B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.457B | 0.00 |
| Progenics Pharmaceuticals (PGNX) | United States | $0.401B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.254B | 0.00 |
| Adamas Pharmaceuticals (ADMS) | United States | $0.166B | 0.00 |
| Akorn (AKRX) | United States | $0.165B | 0.00 |
| CymaBay Therapeutics (CBAY) | United States | $0.134B | 0.00 |
| Zynerba Pharmaceuticals (ZYNE) | United States | $0.132B | 0.00 |
| Teligent (TLGT) | United States | $0.021B | 0.00 |
| China Pharma Holdings (CPHI) | China | $0.018B | 0.00 |
